Quick Win by the Algorithm: OXiGENE Inc. (OXGN)

Quick Win by the Algorithm


On May 20th, 2016, the I Know First algorithm gave a bullish signal of 12.26 for the ticker OXGN with a predictability indicator of 0.14. In accordance with the algorithm’s prediction, OXGN jumped 47.02% in the following three days.

quick win

OXiGENE, Inc. is a biopharmaceutical company. The Company is focused on the development of vascular disrupting agents (VDAs) for the treatment of cancer.
Shares of Oxigene Inc surged higher by more than 40% last week. Investors and traders reacted to Oxigene’s announcement that the “Journal of Clinical Oncology” published a favorable article detailing results from the company’s Study “GOG-0186I”. This also marks the first published report of the beneficial effects of combination vascular targeted therapy for women with recurrent ovarian cancer.

The study consists of 107 patients at 67 sites. The study has already met its primary endpoint by demonstrating a statistically significant improvement in PFS for patients receiving the CA4P combination compared to the control.

“I’m excited about the therapeutic potential of CA4P when used in combination with bevacizumab for the treatment of recurrent ovarian cancer,” stated Bradley J. Monk, M.D., director of the division of gynecologic oncology at St. Joseph’s Hospital and Medical Center and the principal investigator of the study.